Trimethylaminuria
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Trimethylaminuria Classification and external resources | |
 | |
|---|---|
| Trimethylamine | |
| ICD-10 | E88.8 |
| ICD-9 | 270.8 |
| OMIM | 602079 |
| DiseasesDB | 4835 |
|
WikiDoc Resources for Trimethylaminuria | |
|
Articles | |
|---|---|
|
Most recent articles on Trimethylaminuria Most cited articles on Trimethylaminuria | |
|
Media | |
|
Powerpoint slides on Trimethylaminuria | |
|
Evidence Based Medicine | |
|
Cochrane Collaboration on Trimethylaminuria | |
|
Clinical Trials | |
|
Ongoing Trials on Trimethylaminuria at Clinical Trials.gov Trial results on Trimethylaminuria Clinical Trials on Trimethylaminuria at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Trimethylaminuria NICE Guidance on Trimethylaminuria
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Trimethylaminuria Discussion groups on Trimethylaminuria Patient Handouts on Trimethylaminuria Directions to Hospitals Treating Trimethylaminuria Risk calculators and risk factors for Trimethylaminuria
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Trimethylaminuria | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Trimethylaminuria (TMAU), also known as fish odor syndrome or fish malodor syndrome[1], is a rare metabolic disorder that causes a defect in the normal production of the enzyme Flavin containing monooxygenase 3 (FMO3).[2][3] When FMO3 is not working correctly or if not enough enzyme is produced, the body loses the ability to properly breakdown trimethylamine (TMA) from precursor compounds in food into trimethylamine oxide (TMAO) through a process called N-oxygenation. Trimethylamine then builds up and is released in the person's sweat, urine, and breath, giving off a strong fishy odor.
History
The first clinical case of TMAU was described in 1970 in the medical journal The Lancet,[4] but literary references go back more than a thousand years. Shakespeare's Tempest describes the outcast Caliban, "He smells like a fish; a very ancient and fish-like smell...". Hindu folklore mentions in the epic Mahabharata (compiled around 400 AD) a maiden who "grew to be comely and fair, but a fishy odor ever clung to her."
Symptoms
Trimethylamine builds up in the body of patients with trimethylaminuria. The trimethylamine gets released in the person's sweat, urine, reproductive fluids, and breath, giving off a strong fishy odor. Some people with trimethylaminuria have a strong odor all the time, but most have a moderate smell that varies in intensity over time. Individuals with this condition do not have any physical symptoms, and typically appear healthy.[5]
The condition seems to be more common in women than men, but scientists don't know why. Scientists suspect that female sex hormones, such as progesterone and/or estrogen, aggravate symptoms. There are several reports that the condition worsens around puberty. In women, symptoms can worsen just before and during menstrual periods, after taking oral contraceptives, and around menopause.[5]
This odor varies depending on many known factors, including diet, hormonal changes, other odors in the space, and individual sense of smell.
Incidence
TMAU is a life-disruptive disorder caused by both genetic and environmental factors. Living with TMAU is challenging, and it can adversely affect the livelihood of adults who have it and their families. Children with the condition could face rejection or a lack of understanding from peers during school or at play. There are various online support groups that have been created to help those in with malodor issues such as TMAU. The Yahoo TMAU support group [2] is listed in the National Institute of Healths publication "Learning About Trimethylaminuria" [3].
Diagnosis
Measurement of urine for the ratio of trimethylamine to trimethylamine oxide is the standard screening test. A blood test is available to provide genetic analysis. The prominent enzyme responsible for TMA N-oxygenation is coded by the FMO3 gene.
A similar test can be used to identify carriers of this condition - those individuals who carry one copy of a mutated gene but do not have symptoms. In this case, the person would be given a high dose of choline (one of the precursors of trimethylamine) and then have their urine tested for elevated levels of trimethylamine.
TMAU is a rare disorder. There used to be very limited medical knowledge readily available about most rare disorders or how to get tested for them. However, health care professionals can now get helpful information from genetic and rare disorder databases.
Treatment
Currently, there is no cure and treatment options are limited. Although there is no perfect cure for trimethylaminuria, it is possible for some people with this condition to live relatively normal, healthy lives without the fear of being shunned because of their unpleasant odor. Getting tested is an important first step. Ways of reducing the odor include:
- Avoiding foods such as eggs, legumes, certain meats, fish, and foods that contain choline, carnitine, nitrogen, and sulfur
- Taking low doses of antibiotics to reduce the amount of bacteria in the gut
- Using slightly acidic detergents with a pH between 5.5 and 6.5
- At least one study[6] has suggested that the daily intake of charcoal and/or copper chlorophyllin may be of significant use in improving the quality of life of individuals suffering mild forms of TMAU, the success rates vary:
- 85% of people tested completely lost their "fishy" odor
- 10% partially lost their odor
- 5% kept the scent
However, whilst they may be beneficial in some cases, many people in trimethylaminuria support groups who have tried charcoal and copper chlorophyllin have reported disappointing results.
Also helpful are:
- Behavioral counseling to help with depression and other psychological symptoms
- Genetic counseling to better understand their condition
Genetics
Most cases of trimethylaminuria appear to be inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered. The parents of an individual with an autosomal recessive disorder are carriers of one copy of the altered gene. Carriers may have mild symptoms of trimethylaminuria or experience temporary episodes of fish-like body odor.
Mutations in the FMO3 gene, which is found on the long arm of chromosome 1, cause trimethylaminuria. The FMO3 gene makes an enzyme that breaks down nitrogen-containing compounds from the diet, including trimethylamine. This compound is produced by bacteria in the intestine as they digest proteins from eggs, meat, soy, and other foods. Normally, the FMO3 enzyme converts fishy-smelling trimethylamine into trimethylamine N-oxide which has no odor. If the enzyme is missing or its activity is reduced because of a mutation in the FMO3 gene, trimethylamine is not broken down and instead builds up in the body. As the compound is released in a person's sweat, urine, and breath, it causes the strong odor characteristic of trimethylaminuria. Researchers believe that stress and diet also play a role in triggering symptoms.
There are more than 40 known mutations associated with TMAU.[7][8] Loss-of-function mutations, nonsense mutations, and missense mutations are three of the most common. Nonsense and missense mutations cause the most severe phenotypes. Although FMO3 mutations account for most known cases of trimethylaminuria, some cases are caused by other factors. A fish-like body odor could result from an excess of certain proteins in the diet or from an increase in bacteria that normally break down trimethylamine in the digestive system. A few cases of the disorder have been identified in adults with liver damage caused by hepatitis.
The evolution of the FMO3 gene has recently been studied including the evolution of some mutations associated with TMAU. [9]
References
- ↑ Mitchell SC, Smith RL (2001). "Trimethylaminuria: the fish malodor syndrome". Drug Metab Dispos 29 (4 Pt 2): 517–21. PMID 11259343.
- ↑ Treacy EP, et al. (1998). "Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication". Human Molecular Genetics 7 (5): 839–45. doi:10.1093/hmg/7.5.839. PMID 9536088.
- ↑ Zschocke J, Kohlmueller D, Quak E, Meissner T, Hoffmann GF, Mayatepek E (1999). "Mild trimethylaminuria caused by common variants in FMO3 gene". Lancet 354 (9181): 834–5. PMID 10485731.
- ↑ Humbert JA, Hammond KB, Hathaway WE. (1970). "Trimethylaminuria: the fish-odour syndrome". Lancet 2 (7676): 770–1. doi:10.1016/S0140-6736(70)90241-2. PMID 4195988.
- ↑ 5.0 5.1 genome.gov | Learning About Trimethylaminuria
- ↑ Yamazaki H, Fujieda M, Togashi M, et al (2004). "Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients". Life Sci. 74 (22): 2739–47. doi:10.1016/j.lfs.2003.10.022. PMID 15043988.
- ↑ Hernandez D, Addou S, Lee D, Orengo C, Shephard EA, Phillips IR (2003). "Trimethylaminuria and a human FMO3 mutation database". Hum Mutat 22 (3): 209–13. doi:10.1002/humu.10252. PMID 12938085.
- ↑ Furnes B, Feng J, Sommer SS, Schlenk D (2003). "Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans". Drug Metab Dispos 31 (2): 187–93. doi:10.1124/dmd.31.2.187. PMID 12527699.
- ↑ Allerston CK, Shimizu M, Fujieda M, Shephard EA, Yamazaki H, Phillips IR (2007). "Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3)". Pharmacogenet Genomics. 17 (10): 827–39. doi:10.1097/FPC.0b013e328256b198. PMID 17885620.
Trimethylaminuria foundation
The Trimethylaminuria Foundation is a 501 3 (C) non-profit corporation. The address is P.O. BOX 3361, Grand Central Station, New York, NY, 10163. Telephone: 212-300-4168.
External links
This article incorporates public domain text from The U.S. National Library of Medicine and The National Human Genome Research Institute
- page on TMAU at Monell Chemical Senses Center
- story on TMAU at ABC Primetime
- http://health.groups.yahoo.com/group/Trimethylaminuria/ [Online Support Group]
- Tamara McLean, "Woman's fishy-smelling mystery solved" Austrailian News Site, (October 19, 2008 12:00am) (accessed 22 October 2008).
WikiDoc Research Resources for Trimethylaminuria | |
|---|---|
| Articles on Trimethylaminuria | Most recent articles on Trimethylaminuria • Most cited articles on Trimethylaminuria • Review articles on Trimethylaminuria • Articles on Trimethylaminuria in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Trimethylaminuria | Powerpoint slides on Trimethylaminuria • Images of Trimethylaminuria • Photos of Trimethylaminuria • Podcasts & MP3s on Trimethylaminuria • Videos on Trimethylaminuria |
| Evidence Based Medicine Regarding Trimethylaminuria | Cochrane Collaboration on Trimethylaminuria • Bandolier on Trimethylaminuria • TRIP on Trimethylaminuria |
| Cost Effectiveness of Trimethylaminuria | Cost Effectiveness of Trimethylaminuria |
| Clinical Trials Involving Trimethylaminuria | Ongoing Trials on Trimethylaminuria at Clinical Trials.gov • Trial results on Trimethylaminuria • Clinical Trials on Trimethylaminuria at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Trimethylaminuria | US National Guidelines Clearinghouse on Trimethylaminuria • NICE Guidance on Trimethylaminuria • NHS PRODIGY Guidance • FDA on Trimethylaminuria • CDC on Trimethylaminuria |
| Textbook Information on Trimethylaminuria | Books and Textbook Information on Trimethylaminuria |
| Pharmacology Resources on Trimethylaminuria | Dosing of Trimethylaminuria • Drug interactions with Trimethylaminuria • Side effects of Trimethylaminuria • Allergic reactions to Trimethylaminuria • Overdose information on Trimethylaminuria • Carcinogenicity information on Trimethylaminuria • Trimethylaminuria in pregnancy • Pharmacokinetics of Trimethylaminuria • |
| Genetics, Pharmacogenomics, and Proteinomics of Trimethylaminuria | Genetics of Trimethylaminuria • Pharmacogenomics of Trimethylaminuria • Proteomics of Trimethylaminuria |
| Newstories on Trimethylaminuria | Trimethylaminuria in the news • Be alerted to news on Trimethylaminuria • News trends on Trimethylaminuria |
| Commentary on Trimethylaminuria | Blogs on Trimethylaminuria |
| Patient Resources on Trimethylaminuria | Patient resources on Trimethylaminuria • Discussion groups on Trimethylaminuria • Patient Handouts on Trimethylaminuria • Directions to Hospitals Treating Trimethylaminuria • Risk calculators and risk factors for Trimethylaminuria |
| Healthcare Provider Resources on Trimethylaminuria | Symptoms of Trimethylaminuria • Causes & Risk Factors for Trimethylaminuria • Diagnostic studies for Trimethylaminuria • Treatment of Trimethylaminuria |
| Continuing Medical Education (CME) Programs on Trimethylaminuria | CME Programs on Trimethylaminuria |
| International Resources on Trimethylaminuria | Trimethylaminuria en Espanol • Trimethylaminuria en Francais |
| Business Resources on Trimethylaminuria | Trimethylaminuria in the Marketplace • Patents on Trimethylaminuria |
| Informatics Resources on Trimethylaminuria | List of terms related to Trimethylaminuria |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
